Stay updated with breaking news from Kernel Flow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cybin Inc. , a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, commends Kernel, a...
Bryan Johnson, the founder of neurotech company Kernel, tested his company's brain-scanning helmet after having received ketamine.
FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, May 10, 2022 /PRNewswire/ -- Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma.
(2022-05-09 | NEO:CYBN) Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine's Effects on the Brain
/PRNewswire/ -- Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults each year, and despite the abundance...